Dr. Reddy's Laboratories Ltd. 500124 shares slipped 2.23% to 1,197.40 Indian rupees Monday, on what proved to be an ...
3don MSN
CEO of Dr Reddy's Laboratories, Erez Israeli believes his company's affordable medicines benefit the U.S. market and will be ...
Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after ...
Dr. Reddy's Laboratories Ltd. 500124 shares slid 5.01% to 1,224.70 Indian rupees Friday, on what proved to be an all-around ...
Dr Reddy's Laboratories Ltd (RDY) reports a robust 16% YoY revenue growth, driven by strategic product launches and market ...
Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...
Dr. Reddy's Laboratories Ltd (NYSE:RDY) stock is trading lower after the company released third-quarter 2025 earnings. The pharma company clocked a net income of $165 million, marginally up from $161 ...
Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) is expected to be announcing its earnings results on Wednesday, January ...
Indian generic drugmaker Dr Reddys Laboratories expressed optimism about the Donald Trump administration on Thursday, citing ...
Dr Reddy's Laboratories reported a 2% increase in net profit to Rs 1,413 crore for the third quarter ending December 2024.
Dr Reddy's Laboratories posted a 2% rise in net profit for Q3 2024, reaching Rs 1,413 crore, driven by strong market ...
Pharmaceutical major Dr Reddy's Laboratories Ltd on Thursday (January 23) reported a 2.5% year-on-year (YoY) increase in net ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback